Gracell Biotechnologies I... (GRCL)

AI Score

Unlock

10.25

0.01 (0.05%)

At close: Feb 21, 2024, 9:00 PM

Gracell Biotechnologies Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	366K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	366K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-121.75M	-141.15M	-166.59M	-149.32M	-169.78M	-145.82M	-159.73M	-139.58M	-131.11M	-95.69M	-97.19M	-85.48M	-48.17M	-47.77M	-32.98M	-45.89M
Interest Income	9.91M	5.27M	14.63M	15.14M	3.58M	2.7M	2.5M	3.46M	2.98M	1.73M	932K	454K	250K	1M	1.16M	1.44M
Pretax Income	-67.61M	-146.92M	-151.71M	-130.67M	-171.93M	-146.31M	-158.58M	-128.59M	-129.28M	-96.22M	-97.67M	-83.59M	-50.57M	-45.78M	-31.95M	-42.8M
Net Income	-67.63M	-146.93M	-151.73M	-130.69M	-172.21M	-145.13M	-156.01M	-128.59M	-129.28M	-96.22M	-97.67M	-83.59M	-50.57M	-45.78M	-31.95M	-42.8M
Selling & General & Admin	31.7M	37.35M	29.09M	36.18M	36.43M	28.77M	37.89M	32M	42.86M	30.42M	31.76M	24.79M	8.18M	6.97M	5.63M	7.92M
Research & Development	90.05M	103.8M	137.51M	113.14M	133.35M	117.06M	121.84M	107.58M	88.62M	65.27M	65.43M	60.69M	39.99M	40.8M	27.36M	37.97M
Other Expenses	2.4M	1.68M	630K	3.99M	2.23M	1.8M	144K	8.25M	733K	-48K	128K	2.91M	223K	1.57M	-10K	1.22M
Operating Expenses	121.75M	141.15M	166.59M	149.32M	169.78M	145.82M	159.73M	139.58M	131.48M	95.69M	97.19M	85.48M	48.17M	47.77M	32.98M	45.89M
Interest Expense	1.29M	1.7M	1.66M	1.79M	1.86M	1.66M	1.43M	1.33M	1.09M	1.41M	1.24M	805K	654K	490K	206K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	121.75M	141.15M	166.59M	149.32M	169.78M	145.82M	159.73M	139.58M	131.48M	95.69M	97.19M	85.48M	48.17M	47.77M	32.98M	45.89M
Income Tax Expense	13K	10K	16K	22K	279K	-1.18M	-2.57M	-12.32M	-1.9M	-322K	303K	-5.63M	404K	-513K	-957K	-6.7M
Shares Outstanding (Basic)	83.92M	68.13M	67.71M	67.69M	67.68M	67.67M	67.63M	65.77M	67.3M	67.23M	60.9M	60.9M	65.56M	19.81M	19.81M	19.81M
Shares Outstanding (Diluted)	83.92M	68.27M	67.71M	67.69M	67.68M	67.67M	67.63M	65.77M	67.3M	67.23M	60.9M	60.9M	65.56M	19.81M	19.81M	19.81M
EPS (Basic)	-0.81	-2.15	-2.24	-1.93	-2.54	-2.14	-2.31	-1.95	-1.92	-1.43	-1.6	-1.37	-0.77	-2.31	-1.61	-2.16
EPS (Diluted)	-0.81	-2.15	-2.24	-1.93	-2.54	-2.14	-2.31	-1.95	-1.92	-1.43	-1.6	-1.37	-0.77	-2.31	-1.61	-2.16
EBITDA	-109.45M	-134.2M	-151.34M	-130.2M	-163.97M	-141.32M	-157.09M	-127.86M	-127.39M	-94M	-96.13M	-72.76M	-47.7M	-45.2M	-31.83M	-49.83M
EBIT	-74.94M	-145.22M	-150.06M	-128.88M	-170.06M	-144.65M	-157.16M	-127.26M	-128.2M	-94.81M	-96.43M	-82.79M	-49.91M	-45.3M	-31.75M	n/a
Depreciation & Amortization	12.31M	6.95M	15.26M	19.13M	5.81M	4.5M	2.64M	12.32M	3.72M	1.69M	1.06M	9.35M	473K	2.57M	1.15M	1.32M